United Therapeutics (UTHR) Tax Provisions (2009 - 2026)
United Therapeutics (UTHR) posted Tax Provisions of $43.4 million for Q1 2026, down 45.55% sequentially from $79.7 million in Q4 2025, and down 57.16% YoY from $101.3 million in Q1 2025.
United Therapeutics (UTHR) Tax Provisions (2009 - 2026) Analysis & Trends
United Therapeutics has reported Tax Provisions for 18 years, with the latest figure at $43.4 million in Q1 2026.
- Quarterly Tax Provisions fell 57.16% year-over-year to $43.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $321.3 million (down 9.03% YoY) and the FY2025 annual result came in at $379.2 million, up 10.26% from the prior year.
- Tax Provisions fell to $43.4 million in Q1 2026 per UTHR's latest filing, from $79.7 million in the prior quarter.
- Over five years, Tax Provisions peaked at $101.3 million in Q1 2025 and troughed at $34.6 million in Q2 2022.
- A 5-year average of $75.3 million and a median of $78.3 million in 2023 frame the typical range for Tax Provisions.
- The sharpest annual moves came in 2022 and 2026: Tax Provisions jumped 1538.1% in 2022, then slumped 57.16% in 2026.
- Over 5 years, Tax Provisions stood at $46.7 million in 2022, then soared by 67.67% to $78.3 million in 2023, then increased by 21.58% to $95.2 million in 2024, then dropped by 16.28% to $79.7 million in 2025, then tumbled by 45.55% to $43.4 million in 2026.
- According to Business Quant data, Tax Provisions over the past three periods registered $43.4 million, $79.7 million, and $99.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | 121.00 Mn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | -310.32 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 39.70 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 54.80 Mn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 17.80 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 2.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Alkermes | 8.21 Bn | 7.55 Bn | 397.90 Mn | -2.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 39.70 Mn |
| Mar 31, 2026 | 43.40 Mn |
| Dec 31, 2025 | 79.70 Mn |
| Sep 30, 2025 | 99.30 Mn |
| Jun 30, 2025 | 98.90 Mn |
| Mar 31, 2025 | 101.30 Mn |
| Dec 31, 2024 | 95.20 Mn |
| Sep 30, 2024 | 79.50 Mn |
| Jun 30, 2024 | 77.20 Mn |
| Mar 31, 2024 | 92.00 Mn |
| Dec 31, 2023 | 78.30 Mn |
| Sep 30, 2023 | 84.20 Mn |
| Jun 30, 2023 | 76.00 Mn |
| Mar 31, 2023 | 51.00 Mn |
| Dec 31, 2022 | 46.70 Mn |
| Sep 30, 2022 | 73.20 Mn |
| Jun 30, 2022 | 34.60 Mn |
| Mar 31, 2022 | 68.80 Mn |
| Dec 31, 2021 | 28.30 Mn |
| Sep 30, 2021 | 41.70 Mn |